Authors: SANDERINK GJ BOURNIQUE B STEVENS J PETRY M MARTINET M

Citation: Gj. Sanderink et al., INVOLVEMENT OF HUMAN CYP1A ISOENZYMES IN THE METABOLISM AND DRUG-INTERACTIONS OF RILUZOLE IN-VITRO, The Journal of pharmacology and experimental therapeutics, 282(3), 1997, pp. 1465-1472

Authors: LOKIEC F DUSORBIER BM SANDERINK GJ

Citation: F. Lokiec et al., IRINOTECAN (CPT-11) METABOLITES IN HUMAN BILE AND URINE, Clinical cancer research, 2(12), 1996, pp. 1943-1949

Authors: MARRE F SANDERINK GJ DESOUSA G GAILLARD C MARTINET M RAHMANI R

Citation: F. Marre et al., HEPATIC BIOTRANSFORMATION OF DOCETAXEL (TAXOTERE(R)) IN-VITRO - INVOLVEMENT OF THE CYP3A SUBFAMILY IN HUMANS, Cancer research, 56(6), 1996, pp. 1296-1302

Authors: BISSERY MC NOHYNEK G SANDERINK GJ LAVELLE F

Citation: Mc. Bissery et al., DOCETAXEL (TAXOTERE(R)) - A REVIEW OF PRECLINICAL AND CLINICAL-EXPERIENCE .1. PRECLINICAL EXPERIENCE, Anti-cancer drugs, 6(3), 1995, pp. 339-355

Authors: BRUNO R SANDERINK GJ

Citation: R. Bruno et Gj. Sanderink, PHARMACOKINETICS AND METABOLISM OF TAXOTERE(TM) (DOCETAXEL), Cancer surveys, 17, 1993, pp. 305-313